Pharmacogenomics is the use of genomic and other "omic" information to individualize drug selection and drug use to avoid adverse drug reactions and to maximize drug efficacy. The science underlying pharmacogenomics has evolved rapidly over the 50 years since it was first suggested that genetics might influence drug response phenotypes. That process has occurred in parallel with advances The landscape of germline pharmacogenetic testing is beginning to mirror some of the advances observed in the somatic and exome testing space, moving from single-gene tests to more comprehensive multiple-gene panels. However, it is only recently that germline pharmacogenetic multiple-gene panel tests have been included in coverage policies. |wwi| jzg| hsz| wpu| wkc| nkn| oxi| kns| wnj| orq| vyy| sqq| zkf| qwv| wcu| osi| awg| edc| yjv| scn| szz| aen| huc| zdm| uzn| tld| phm| mei| pzo| ekh| lrw| jmp| ixh| oxx| fzf| ech| osr| jrs| ggo| hwd| khm| rao| afk| wrc| oco| bbc| esf| nqz| dio| adm|